Axon sees FY22 revenue $1.15B-$1.16B, consensus $1.11B

Previous guidance was $1.07B-$1.12B. The company said: "We now expect to deliver 2022 Adjusted EBITDA between $215 million and $220 million, compared with our previous expectation that we would deliver Adjusted EBITDA of about $200 million. Our guidance implies Q4 2022 Adjusted EBITDA of $49 million to $54 million. We now expect adjusted free cash flow to come in above the midpoint of our previously communicated range of $125 million to $145 million. We now expect 2022 capital expenditures of $70 million to $80 million, compared with our previous range of $80 million to $90 million, as some investments have pushed into next year."